Growth in children undergoing bone marrow transplantation (BMT) after conditioning with busulfan and cyclophosphamide.

被引：0
|
作者：
Shankar, SM [1 ]
Bunin, NJ [1 ]
Moshang, T [1 ]
机构：
[1] CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3848 / 3848
页数：1
相关论文
共 50 条
  • [1] Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning
    Shankar, SM
    Bunin, NJ
    Moshang, T
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1996, 18 (04) : 362 - 366
  • [2] ENGRAFTMENT FAILURE FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) IN CHILDREN WITH THALASSEMIA MAJOR USING BUSULFAN AND CYCLOPHOSPHAMIDE CONDITIONING
    RAO, K
    DACUNHA, AM
    PADMOS, A
    GIRI, N
    SPENCE, D
    CLINK, H
    ERNST, P
    SOLH, H
    BLOOD, 1993, 82 (10) : A640 - A640
  • [3] Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen
    Arslan, O
    Akan, H
    Koc, H
    Beksac, M
    Ilhan, O
    Ozcan, M
    Yalcin, S
    Gurman, G
    Konuk, N
    Uysal, A
    BONE MARROW TRANSPLANTATION, 1996, 18 (01) : 261 - 261
  • [4] HIGH-DOSE BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) AS CONDITIONING REGIMEN IN BONE-MARROW TRANSPLANTATION (BMT)
    QUABECK, K
    BEELEN, DW
    SAYER, H
    GRAEVEN, U
    SCHAEFER, UW
    SCHMIDT, CG
    BLUT, 1987, 55 (04): : 374 - 374
  • [5] HEMATOPOIETIC RECONSTITUTION AFTER BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SZCZYLIK, C
    RATAJCZAK, MZ
    URBANOWSKA, E
    WIKTORJEDRZEJCZAK, W
    BLUT, 1988, 57 (04): : 235 - 235
  • [6] GROWTH EVALUATION IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION (BMT)
    SANDLER, ES
    KNUTH, CL
    GRAHAMPOLE, JR
    SILVERSTEIN, JH
    KEDAR, A
    CONNER, KG
    ROSENBLOOM, AL
    PEDIATRIC RESEARCH, 1990, 27 (04) : A86 - A86
  • [7] BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE-MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES
    LOCATELLI, F
    PESSION, A
    BONETTI, F
    MASERATI, E
    PRETE, L
    PEDRAZZOLI, P
    ZECCA, M
    PRETE, A
    PAOLUCCI, P
    CAZZOLA, M
    LEUKEMIA, 1994, 8 (05) : 844 - 849
  • [8] Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation
    Shah, AJ
    Lenarsky, C
    Kapoor, N
    Crooks, GM
    Kohn, DB
    Parkman, R
    Epport, K
    Wilson, K
    Weinberg, K
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (02) : 91 - 97
  • [9] Early toxicity of intensified conditioning with etoposide combined with total body irradiation cyclophosphamide or busulfan cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation
    Horstmann, M
    Kroschke, G
    Stockschlader, M
    Betker, R
    Kruger, W
    Erttmann, R
    Kabisch, H
    Zander, A
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1996, 13 (01) : 45 - 53
  • [10] BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA
    ODONNELL, MR
    LONG, GD
    PARKER, PM
    NILAND, J
    NADEMANEE, A
    AMYLON, M
    CHAO, N
    NEGRIN, RS
    SCHMIDT, GM
    SLOVAK, ML
    SMITH, EP
    SNYDER, DS
    STEIN, AS
    TRAWEEK, T
    BLUME, KG
    FORMAN, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2973 - 2979
12345